Word: ago
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
...Prime Minister clung to his job until a weekend news story reported that Ihei Aoki, his right-hand man, had received a 50 million-yen ($347,222) loan from the Recruit Co. two years ago that apparently found its way into the Takeshita campaign chest. The disclosure flatly contradicted the version of events that Takeshita had laid out before the Japanese Diet in early April. Two days after the Aoki story broke, Takeshita came to the conclusion that he could not keep his job; public disapproval was so strong that his government's popularity rating had plummeted to a mortifying...
...moves helped restore calm to what has traditionally been the Middle East's most stable nation. But the outburst caught the government by surprise and signaled that something more was awry than momentary resentment over price hikes imposed two weeks ago...
...peak of good health. Thanks largely to Valium and its sister sedative, Librium, the Swiss-based Hoffmann-La Roche became the No. 1 maker of prescription pharmaceuticals and one of the most profitable companies on earth. But lulled by the success of Valium, whose U.S. patent expired four years ago, the company failed to keep pace in the '80s with such aggressive rivals as U.S.-based Merck and Swiss neighbors Sandoz and Ciba-Geigy. Symbolic of Hoffmann-La Roche's backward ways was the firm's thinly held stock, the most expensive traded anywhere. In the past year the price...
...years ago, the Sacher family called in Gerber, who headed the Zurich Insurance Co., to take over Hoffmann-La Roche, whose Valium profits had tranquilized it into lethargy. He streamlined the administration, production and research and set out to find a new generation of superstar drugs. The antibiotic Rocephin, which had worldwide sales last year of $445 million, is currently the firm's largest-selling product. Valium, though, remains the second-best seller. Last week the company reported that 1988 profits had risen to $389 million, up 33% from the previous year, on sales of $5.3 billion. Now that Hoffmann...
...year ago Hoffmann-La Roche bearer shares traded at $129,000 and Baby Roche...